Evidence map›Paper›PMID 6219064›Full record

ArticleImmunology1983

Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.

A F López, M Strath, C J Sanderson

Open access · greenAbstract read
In one paragraph

Article in Immunology, 1983. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A F López
M Strath
C J Sanderson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytotoxic activity of mouse eosinophils and neutrophils in the presence of antibodies of different isotypes has been studied. Mouse monoclonal anti-hapten antibodies of all the known mouse immunoglobulin isotypes have been used to coat hapten-coupled, 51Cr-labelled target cells. Two different target cells have been used, sheep red cells, as a model for intracellular killing, and BW cell line cells, as a model for extracellular killing. It is shown that both eosinophils and neutrophils lyse sheep red cells coated with IgG1, IgG2a and IgG2b and to a lesser extent IgG3. No killing is detected when sheep red cells are coated with IgM, IgA or IgD. Neutrophils, but not eosinophils are shown to lyse IgE-coated sheep red cells. When tested against BW cells, neutrophils have been found to induce high levels of 51Cr release in the presence of IgG1, IgG2a, IgG2b and IgE, but not when IgG3, IgM, IgA or IgD were used. In contrast, no killing of BW cells by eosinophils could be detected with any of the different antibody isotypes tested. However, it is shown that eosinophils are able to kill IgG-coated BW cells when hapten coupling is increased to maximum levels or when complement is added into the system, emphasizing our previous results showing that eosinophils require much higher levels of ligands than neutrophils to be effective. To test the possibility that eosinophils have a weak IgE receptor, complement was added to IgE-coated BW cells by means of a monoclonal IgM anti-Thy-1 antibody but no cytotoxicity was detected. It cannot be completely excluded that eosinophils have IgE blocking a putative IgE receptor.

Indexed as

Antibody-Dependent Cell CytotoxicityAnimalsEosinophilsErythrocytesImmunoglobulin EImmunoglobulin GImmunoglobulinsMiceMice, Inbred BALB CNeoplasms, ExperimentalNeutrophilsReceptors, IgEReceptors, ImmunologicImmunoglobulin EImmunoglobulin GImmunoglobulinsReceptors, IgEReceptors, Immunologic

Identifiers

PMID6219064
PMCPMC1454033
OpenAlexW47500171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.